The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.

Antibiotic resistance is a major threat to human health. But experts say there are steps people can take to reduce the risk.

Former Kent State coach Herb Page might've been undergoing chemotherapy on Thursday in Ohio, but he wasn't going to miss a ...

Large cap index funds fall in the passive fund category. From an investor's perspective, they get a chance to invest in India's blue-chip companies through a single fund. Since funds have a high ...

An antibiotic that is commonly used for urinary tract infections effectively treated gonorrhoea, and may even work against ...

Gonorrhoea is resistant to nearly all antibiotics, but one commonly used for urinary tract infections (UTIs) may be able to treat drug-resistant cases. The sexually transmitted infection (STI) is ...

Rowing crews from British universities Oxford and Cambridge will compete in the men’s and women’s Boat Race on Sunday.

Stock markets plunged again on Thursday as the White House confirmed China will be hit with 145 per cent tariffs.

Mortgage applications are an early indicator of sales activity in the housing market. - A brief, big dip in mortgage rates ...

"The approval of Blujepa is a crucial milestone with uUTIs among the most common infections in women," said GSK's chief scientific offer Tony Wood, pointing out that around 16 million women in the ...